Evidence map›Paper›PMID 23378533›Full record

ArticleThe Journal of biological chemistry2013

Replacement of all arginine residues with canavanine in MazF-bs mRNA interferase changes its specificity.

Yojiro Ishida, Jung-Ho Park, Lili Mao, Yoshihiro Yamaguchi, Masayori Inouye

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Conserved Amino Acid Moieties ofFrontiers in microbiology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yojiro IshidaDepartment of Biochemistry, Robert Wood Johnson Medical School and Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey 08854.
Jung-Ho ParkDepartment of Biochemistry, Robert Wood Johnson Medical School and Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey 08854.
Lili MaoDepartment of Biochemistry, Robert Wood Johnson Medical School and Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey 08854.
Yoshihiro YamaguchiDepartment of Biochemistry, Robert Wood Johnson Medical School and Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey 08854.
Masayori InouyeDepartment of Biochemistry, Robert Wood Johnson Medical School and Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey 08854. Electronic address: inouye@cabm.rutgers.edu.
Johnson University · US

Funding

Deciphering of the Toxin-Antitoxin Systems in E. coliR01GM081567 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI INOUYE, MASAYORI · 2009 to 2012
$1.8M
NIGMS NIH HHS R01 GM081567NIGMS NIH HHS R01GM081567
6 · The paper itself

Abstract

Replacement of a specific amino acid residue in a protein with nonnatural analogues is highly challenging because of their cellular toxicity. We demonstrate for the first time the replacement of all arginine (Arg) residues in a protein with canavanine (Can), a toxic Arg analogue. All Arg residues in the 5-base specific (UACAU) mRNA interferase from Bacillus subtilis (MazF-bs(arg)) were replaced with Can by using the single-protein production system in Escherichia coli. The resulting MazF-bs(can) gained a 6-base recognition sequence, UACAUA, for RNA cleavage instead of the 5-base sequence, UACAU, for MazF-bs(arg). Mass spectrometry analysis confirmed that all Arg residues were replaced with Can. The present system offers a novel approach to create new functional proteins by replacing a specific amino acid in a protein with its analogues.

Indexed as

Amino Acid SequenceArginineBacillus subtilisBase SequenceBinding, CompetitiveCanavanineCircular DichroismDNA-Binding ProteinsDNA PrimersEndoribonucleasesEscherichia coliEscherichia coli ProteinsKineticsMass SpectrometryModels, ChemicalModels, MolecularArginineCanavanineDNA-Binding ProteinsDNA PrimersEndoribonucleasesEscherichia coli ProteinsMazF protein, E coliRNA, Messenger

Identifiers

PMID23378533
PMCPMC3597797
OpenAlexW1964014127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.